United States · FDA National Drug Code directory

Hydrochlorothiazide

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-1713_c545f051-9fce-4a1f-b98b-6ef78b63a7ed
Product NDC
71335-1713
Form
CAPSULE
Composition / generic term
Hydrochlorothiazide
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20190114
Source listing expiry
20271231

Source-listed ingredients

  • HYDROCHLOROTHIAZIDE — 12.5 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE in 1 BOTTLE (71335-1713-1) · 71335-1713-1
  • 10 CAPSULE in 1 BOTTLE (71335-1713-2) · 71335-1713-2
  • 90 CAPSULE in 1 BOTTLE (71335-1713-3) · 71335-1713-3
  • 100 CAPSULE in 1 BOTTLE (71335-1713-4) · 71335-1713-4
  • 60 CAPSULE in 1 BOTTLE (71335-1713-5) · 71335-1713-5
  • 120 CAPSULE in 1 BOTTLE (71335-1713-6) · 71335-1713-6
  • 7 CAPSULE in 1 BOTTLE (71335-1713-7) · 71335-1713-7
  • 15 CAPSULE in 1 BOTTLE (71335-1713-8) · 71335-1713-8
  • 14 CAPSULE in 1 BOTTLE (71335-1713-9) · 71335-1713-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →